| Oct 30 |
Corcept: Q3 Earnings Snapshot
|
| Oct 30 |
Corcept Therapeutics GAAP EPS of $0.41 beats by $0.13, revenue of $182.5M beats by $10.53M
|
| Oct 30 |
Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results From Phase 3 GRADIENT Trial in Patients With Cushing’s Syndrome and Provides Corporate Update
|
| Oct 29 |
Corcept Therapeutics Q3 2024 Earnings Preview
|
| Oct 23 |
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
|
| Oct 23 |
Buy Low-Beta Stocks JD, SKWD, CORT, PRA to Beat Election Uncertainty
|
| Oct 23 |
Zacks.com featured highlights Idaho Strategic, Qifu, Sezzle, Corcept and FinWise
|
| Oct 22 |
5 Stocks With Recent Price Strength to Tap Wall Street Rally
|
| Oct 21 |
Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength?
|
| Oct 17 |
Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High?
|
